Fluidics

Sphere Fluidics Appoints Richard Hammond as Chief Technical Officer

Retrieved on: 
Tuesday, December 13, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Fluidics, Sphere Fluidics, DNA, University of Cambridge, Master of Engineering, Granta Park, MA, Growth, Sphere, University, Consultant, Engineering, Cambridge Consultants, Industrial design

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Richard Hammond as Chief Technical Officer.

Key Points: 
  • Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Richard Hammond as Chief Technical Officer.
  • In his role as Chief Technical Officer, Richard will be responsible for driving innovation and growing Sphere Fluidics product range, including productizing several patented prototypes currently in development.
  • Richard Hammond, MA MEng, joins Sphere Fluidics with over 20 years experience in managing the development of cutting-edge commercial products for healthcare and life sciences.
  • Richard Hammond, CTO, Sphere Fluidics, commented: Sphere Fluidics has an excellent reputation for providing world-class products for single cell analysis, and Im delighted to take the opportunity to build on this further.

Pulmodyne and fluidIQ Sign Licensing, Joint R&D Agreement

Retrieved on: 
Friday, October 7, 2022
Fluidics, Sale, Electricity, Gaps, Medtech, Emergency medicine, Multimedia, Technology, Automation, Miniaturization, Acute, Atmosphere, FDA, Solution, EMS, Emergency, Online shopping

INDIANAPOLIS, Oct. 7, 2022 /PRNewswire/ -- Global manufacturer and distributor of high-quality airway and respiratory products, Pulmodyne, Inc., and fluidics-based MedTech company, fluidIQ, Inc., announced today a global licensing and joint research and development agreement. Pulmodyne, an Intersurgical company, will license fluidIQ's technology.

Key Points: 
  • INDIANAPOLIS, Oct. 7, 2022 /PRNewswire/ -- Global manufacturer and distributor of high-quality airway and respiratory products, Pulmodyne, Inc., and fluidics-based MedTech company, fluidIQ, Inc., announced today a global licensing and joint research and development agreement.
  • "Pulmodyne is thrilled to partner with such a talented group of engineers and designers.
  • "This agreement will allow fluidIQ to license our innovative technology to one of the largest and most respected respiratory and EMS distributors in the world," said Matt Vogelhuber, RPh., Chief Executive Officer of fluidIQ.
  • The global reach of Pulmodyne and its parent company, Intersurgical, will provide wide access to fluidIQ's innovative technologies.

Technicolor Precision BioDevices to Manufacture Scope Fluidics’ BacterOMIC System Cartridges

Retrieved on: 
Monday, August 16, 2021
Medical Devices, Health, Manufacturing, Other Health, Other Manufacturing, Biotechnology, Euronext Paris, TPB, Laboratory, Board, Fluidics, TCH, OTCQX, Solution, Video game console

Technicolor Precision BioDevices (TPB), a member of the creative technology leader Technicolor (Euronext Paris: TCH, OTCQX: TCLRY), announces a collaboration with Scope Fluidics to manufacture cartridges for their BacterOMIC system.

Key Points: 
  • Technicolor Precision BioDevices (TPB), a member of the creative technology leader Technicolor (Euronext Paris: TCH, OTCQX: TCLRY), announces a collaboration with Scope Fluidics to manufacture cartridges for their BacterOMIC system.
  • Established in 2010, they develop solutions with a high market potential across two core divisions: Curiosity Diagnostics and Bacteromic.
  • Technicolor Precision BioDevices will provide small-scale production of the BacterOMIC cartridges.
  • Technicolor will be supporting manufacturing of the BacterOMIC cartridges from its existing production facility in Piaseczno, a suburb of Warsaw, Poland.

Jetoptera Awarded Seven Patents for Fluidic Propulsive System, Vertical Take-Off and Landing Configuration, Variable Geometry Thruster and Flying Car Design

Retrieved on: 
Thursday, March 11, 2021
Emerging technologies, Aviation, Aircraft, Human activities, VTOL, Takeoff and landing, V/STOL, STOL, Fluidics, Flying car, VTOL aircraft, Harrier Jump Jet

10,919,636 and 10,934,011 , entitled FLUIDIC PROPULSIVE SYSTEM AND THRUST AND LIFT GENERATOR FOR AERIAL VEHICLES, issued February 16 and March 2, 2021.

Key Points: 
  • 10,919,636 and 10,934,011 , entitled FLUIDIC PROPULSIVE SYSTEM AND THRUST AND LIFT GENERATOR FOR AERIAL VEHICLES, issued February 16 and March 2, 2021.
  • The flying-car and Fluidic Propulsive Device design patents are the latest in a series of issued design patents and they protect the elegant, efficiently integrated airframe design of Jetopteras aircraft.
  • With the combination of these patents, Jetoptera is uniquely positioned to define the High-Speed VTOL, long-endurance VTOL, modern STOL, and flying car categories.
  • The Fluidic Propulsive System is ideal for vertical and short takeoff and landing applications (V/STOL).

IDEX Health & Science Launches New Intuitive™ Torque Limiting Fitting System

Retrieved on: 
Wednesday, February 3, 2021
Fluid dynamics, Video games, Creative works, Articles, IDEX, Biotechnology, Microfluidics, First-person shooters, Single-player video games, Fluidics, The Suffering

ROHNERT PARK, Calif., Feb. 3, 2021 /PRNewswire-PRWeb/ --IDEX Health & Science, industry leader in fluidic connections for life science applications, has launched the Intuitive Torque Limiting Fitting System which is a patented torque limiting true "Finger Tight" fitting for low pressure connections.

Key Points: 
  • ROHNERT PARK, Calif., Feb. 3, 2021 /PRNewswire-PRWeb/ --IDEX Health & Science, industry leader in fluidic connections for life science applications, has launched the Intuitive Torque Limiting Fitting System which is a patented torque limiting true "Finger Tight" fitting for low pressure connections.
  • The torque limiting technology provides a haptic "click" feedback when it reaches the optimum torque, assuring a perfect connection every time.
  • About IDEX Health & Science, LLC
    IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise.
  • At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives.

Adaptas Solutions Acquires Cadence Fluidics

Retrieved on: 
Monday, December 7, 2020
Science and technology, Articles, Fluid dynamics, Clinical pathology, Fluidics, Logic, Mass spectrometry, Sample preparation in mass spectrometry, Science

PALMER, Mass., Dec. 7, 2020 /PRNewswire/ --Adaptas Solutions, LLC, a leading manufacturer of critical components for mass spectrometers, analytical lab equipment and clinical instruments, has completed the acquisition of Cadence Fluidics.

Key Points: 
  • PALMER, Mass., Dec. 7, 2020 /PRNewswire/ --Adaptas Solutions, LLC, a leading manufacturer of critical components for mass spectrometers, analytical lab equipment and clinical instruments, has completed the acquisition of Cadence Fluidics.
  • Cadence Fluidics manufacturing will be transitioned into Adaptas Solutions' 90,000 square foot ISO 9001:2015 campus in Palmer, MA.
  • "The addition of Cadence will allow us to continue to elevate our market position in the sample preparation and chromatography markets," said Jay Ray, President and CEO of Adaptas Solutions.
  • "I am excited to partner with Adaptas Solutions for the next stage of Cadence Fluidics growth," said Neil Picha, founder of Cadence Fluidics.

IDEX Health & Science Launches New MarvelXACT™ PEEKsil™ Connection System

Retrieved on: 
Tuesday, December 1, 2020
Fluid dynamics, Articles, IDEX, Biotechnology, Microfluidics, Fluidics, Science and technology, Technology

ROHNERT PARK, Calif., Dec. 1, 2020 /PRNewswire-PRWeb/ --IDEX Health & Science, industry leader in fluidic connections for life science applications, has launched the new MarvelXACT PEEKsil Connection Systems.

Key Points: 
  • ROHNERT PARK, Calif., Dec. 1, 2020 /PRNewswire-PRWeb/ --IDEX Health & Science, industry leader in fluidic connections for life science applications, has launched the new MarvelXACT PEEKsil Connection Systems.
  • Other bioinert products supplied by IDEX Health & Science include: MarvelX and MarvelXACT connection technology, 1mm columns, bioinert PEEK-Lined Stainless-Steel Column Hardware and a novel flat film degasser.
  • About IDEX Health & Science, LLC
    IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise.
  • At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives.

Sharp Fluidics® launches NeoClose® AnchorGuard: designed to safely close Laparoscopic and Robotic surgery port sites without insufflation

Retrieved on: 
Thursday, October 22, 2020
Medicine, Clinical medicine, Endoscopy, Digestive system surgery, Laparoscopy, Fluidics, Surgery, Insufflation

NeoClose AnchorGuard is used with the NeoClose anchor technology to enable clinicians to close laparoscopic and robotic port sites without insufflation.

Key Points: 
  • NeoClose AnchorGuard is used with the NeoClose anchor technology to enable clinicians to close laparoscopic and robotic port sites without insufflation.
  • "Sharp Fluidics continues to innovate to make closure safer and faster for clinicians," said Douglas Rimer, President of Sharp Fluidics.
  • NeoClose is faster, safer, and provides less port site pain than the standard practice of closing port sites.
  • In addition to the NeoClose port site closure system, Sharp Fluidics leads the way for more efficient open surgery closure with Operative Armour.

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market: COVID-19 Business Continuity Plan | Evolving Opportunities With AMETEK Inc. and Blacktrace Holdings Ltd. | Technavio

Retrieved on: 
Monday, September 21, 2020
Medical Supplies, Medical devices, Health, Other Health, Managed care, Biotechnology, Articles, Fluidics, Logic, Preclinical development

The global fluidics for preclinical, life science research, and clinical applications market is expected to grow by USD 1.38 billion as per Technavio.

Key Points: 
  • The global fluidics for preclinical, life science research, and clinical applications market is expected to grow by USD 1.38 billion as per Technavio.
  • View the full release here: https://www.businesswire.com/news/home/20200920005038/en/
    Technavio has announced its latest market research report titled Global Fluidics for Preclinical, Life Science Research, and Clinical Applications Market 2020-2024 (Graphic: Business Wire).
  • In addition, the diverse applications of fluidics technology are anticipated to boost the growth of the fluidics for preclinical, life science research, and clinical applications market.
  • Major Five Fluidics for Preclinical, Life Science Research, and Clinical Applications Companies:
    AMETEK Inc. operates its business through segments such as Electronic Instruments and Electromechanical.

Poland: EIB lends up to EUR 10 million to Scope Fluidics to develop diagnostics equipment for infectious diseases

Retrieved on: 
Monday, September 7, 2020
Articles, European Union, Multilateral development banks, Infectious diseases, European Investment Bank, Fluidics, Infection, Infectious disease, Pandemic

The European Investment Bank (EIB) has agreed to lend up to EUR 10 million to Scope Fluidics, a Polish medical technology company developing innovative products in the field of medical diagnostics.

Key Points: 
  • The European Investment Bank (EIB) has agreed to lend up to EUR 10 million to Scope Fluidics, a Polish medical technology company developing innovative products in the field of medical diagnostics.
  • The EIB financing will support the companys efforts to develop new, efficient and affordable methods for detection of pathogens causing infectious diseases, including COVID-19.
  • Testing a broader range of infectious diseases may significantly increase the standard of care and the effectiveness of prevention of complications in the evolving pandemic.
  • The financing comes from a joint European Commission and EIB initiative the Infectious Diseases Finance Facility (IDFF) backed by the Horizon 2020, the EU Research and Innovation programme
    2014-2020.
  • By investing in this project, the Bank will provide a relevant contribution to the scientific advancement in the field of diagnostic equipment for infectious diseases, including COVID-19.
  • On behalf ofthe entire Scope Fluidics team, I would like to thank EIB for the trust of such an experienced institution - says prof. Piotr Garstecki, CEO of Scope Fluidics.
  • With this loan to Scope Fluidics the EU is making one step closer to finding solutions to fight the coronavirus pandemic.
  • Background information The InnovFin Infectious Diseases Finance Facility (IDFF) is a financial product dedicated to support the fight against infectious diseases.
  • Scope Fluidics SAis a hub that grows med-tech start-ups, each developing a radical solution to a challenge in global health.